Voltammetric determination of Molnupiravir used in treatment of the COVID-19 at magnetite nanoparticle modified carbon paste electrode

To reduce the progression of the viral process in patients infected with COVID-19, new treatments and drug active substances are needed. One of these drugs is Molnupiravir (MNP) which has a direct antiviral effect and has also proven to be highly effective in reducing the azopharyngeal SARS-CoV-2 in...

Descripción completa

Detalles Bibliográficos
Autores principales: Vural, Kader, Karakaya, Serkan, Dilgin, Didem Giray, Gökçel, Hatice İsmet, Dilgin, Yusuf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9671532/
https://www.ncbi.nlm.nih.gov/pubmed/36415585
http://dx.doi.org/10.1016/j.microc.2022.108195

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9671532/
https://www.ncbi.nlm.nih.gov/pubmed/36415585
http://dx.doi.org/10.1016/j.microc.2022.108195

Ejemplares similares